Shiga University of Medical Science >ENGLISH
�‘—§‘åŠw–@�l�FŽ ‰êˆã‰È‘åŠw
‘åŠw�Љî �u�À�EŽ{�Ý “üŽŽ�î•ñ ‹³ˆç�EŒ¤‹† ŽYŠw˜AŒg �‘�Û˜AŒg Šw�¶�¶Šˆ •�‘®•a‰@

Ž ‰êˆã‰È‘åŠwTOP > ‹³ˆç�EŒ¤‹† > Šw’·�ÜŽó�ÜŽÒ

TOP‚Ö
Šw’·�ÜŽó�ÜŽÒ
 
�uŠw’·�Ü�v‚Í—D‚ꂽŠwˆÊ˜_•¶‚ɑ΂µ•\�²‚·‚é‚à‚̂ł·�B
 
”ŽŽm˜_•¶Šw’·�Ü�@Žó�ÜŽÒ

”ŽŽm˜_•¶Šw’·�Ü

•�“à�@”ü‹I�i‘ŸŠí�§ŒäŒn�ê�U�j

˜_•¶‘è–Ú�uGlyoxalase-I is a novel target against Bcr-Abl+ leukemic cells acquiring stem-like characteristics in hypoxic environment�v


”ŽŽm˜_•¶Šw’·�Ü

ŠL“c�@�²’mŽq�i‘ŸŠí�§ŒäŒn�ê�U�j

˜_•¶‘è–Ú�uVisible-drug delivery by supra-molecular nanocarriers directing to single-platformed diagnosis and therapy of pancreatic tumor model�v

 
�CŽm˜_•¶Šw’·�Ü�@Žó�ÜŽÒ
”ŽŽm˜_•¶Šw’·�ÜŽó�ÜŽÒ‚ÌŽÊ�^

�CŽm˜_•¶Šw’·�Ü

“y�ì�@�Ë�iŠÅŒìŠw�ê�U�j

˜_•¶‘è–Ú�u•ª•ØŒã‚Ì�œ”Õ’ê’oŠÉ‚ɑ΂·‚é�c’f“I‰î“üŒ¤‹†
�|�œ”Õ’ê‹Ø‘Ì‘€‚ƃTƒ|�[ƒg‰º’…‚Ì”äŠr�|�v

 
‰Û’ö”ŽŽm˜_•¶Šw’·�§—ã�Ü�@Žó�ÜŽÒ
”ŽŽm˜_•¶Šw’·�ÜŽó�ÜŽÒ‚ÌŽÊ�^

‰Û’ö”ŽŽm˜_•¶Šw’·�§—ã�Ü

“ì�@‰À‚Ù‚è�i�Ä�¶�EŽîᇉð�ÍŒn�ê�U�j

˜_•¶‘è–Ú�uDNMT3L is a novel marker and is essential for the growth of human embryonal carcinoma.�v

 
•½�¬21”N“x�@Žó�ÜŽÒ
•½�¬20”N“x�@Žó�ÜŽÒ
•½�¬19”N“x�@Žó�ÜŽÒ
•½�¬18”N“x�@Žó�ÜŽÒ
•½�¬17”N“x�@Žó�ÜŽÒ
•½�¬16”N“x�@Žó�ÜŽÒ
•½�¬15”N“x�@Žó�ÜŽÒ
 
Page Top
 
Œð’Ê�EƒAƒNƒZƒX ƒLƒƒƒ“ƒpƒXƒ}ƒbƒv ‚¨–â‚¢�‡‚¹�æ ƒTƒCƒgƒ}ƒbƒv ‚±‚̃TƒCƒg‚ɂ‚¢‚Ä
  Copyright(C)2005 Shiga University of Medical Science All Rights Reserved.
‚¹